TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
MicroPort CardioFlow Medtech Corp. ( (HK:2160) ) has issued an update.
MicroPort CardioFlow Medtech Corp. announced a significant leadership change with the resignation of Mr. Jeffrey R Lindstrom as Executive Director and President, effective March 27, 2025, to focus on other commitments. Mr. Zhang Ruinian has been appointed as his successor, bringing over 20 years of experience in various medical fields and leadership roles in prominent companies, which may enhance the company’s strategic direction and operations.
More about MicroPort CardioFlow Medtech Corp.
MicroPort CardioFlow Medtech Corp. operates in the medical technology industry, focusing on cardiovascular devices and related medical solutions. The company is part of a larger group with subsidiaries and is listed on the Hong Kong Stock Exchange.
YTD Price Performance: 66.18%
Average Trading Volume: 3,654,845
Technical Sentiment Signal: Sell
Current Market Cap: HK$2.65B
For an in-depth examination of 2160 stock, go to TipRanks’ Stock Analysis page.